Colm Burke (Cork North-Central, Fine Gael)

I have a letter in my hand from Dr. Derville O'Shea, consultant haematologist, in respect of a constituent of mine, Aishling Thornhill, who, unfortunately, has relapsed refractory B-cell acute lymphoblastic leukaemia. It is a complicated condition. My understanding is that treatment would be available to her if she was under 25 but because she is over 25 it is not being made available. I understand some progress was made on it this morning. Could the issue be clarified? Where a consultant prescribes that the treatment would be of benefit to a patient over 25, why is a barrier put in place for them? Could the issue be examined in the overall context?

See this speech in context